HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Intratumor chemotherapy in combination with a systemic antimetastatic drug in the treatment of Lewis-lung carcinoma.

Abstract
The effect of an antimetastatic agent plus intratumor chemotherapy was evaluated in mice bearing Lewis-lung carcinoma by measuring survival time and by histological examination. Polymeric flavan-3,4-diol (APF) from avocado seeds, Persea gratissima, administered alone directly into the tumor did not change survival time, although it partially destroyed the primary tumor. However, the drug administered in combination with an antimetastatic, 1,2-bis(3,5-dioxopiperazin-1-yl)ethane (ICRF-154), resulted in an increase in survival time. When 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU) was used in place of polymeric flavanadiol as an intralesional drug, a significant increase in survival was also achieved. The effect of each drug alone and of their combination was evaluated by "responder analyses". Animals "cured" by the combination and rechallenged with 2 X 10(6) tumor cells showed that immunization could occur.
AuthorsM M De-Oliveira, I T Nakamura, A C Joussef, O Giannotti Filho
JournalBrazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas (Braz J Med Biol Res) Vol. 18 Issue 3 Pg. 293-302 ( 1985) ISSN: 0100-879X [Print] Brazil
PMID3835980 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Chromans
  • Polymers
  • Razoxane
  • 1,2-bis(3,5-dioxopiperazin-1-yl)ethane
  • Carmustine
Topics
  • Animals
  • Antineoplastic Combined Chemotherapy Protocols (therapeutic use)
  • Carmustine (administration & dosage)
  • Chromans (administration & dosage)
  • Injections
  • Lung Neoplasms (drug therapy)
  • Mice
  • Mice, Inbred C57BL
  • Mice, Inbred DBA
  • Polymers (administration & dosage)
  • Razoxane (administration & dosage, analogs & derivatives)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: